Prognostic significance of HTR6 expression and its association with immune infiltration in low-grade glioma
Introduction: Low-grade glioma (LGG), defined herein as WHO grade II and III diffuse gliomas including astrocytomas and oligodendrogliomas, is a clinically and molecularly heterogeneous group of primary brain tumors with variable outcomes, highlighting the need for reliable prognostic biomarkers and immune-related ther...